Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
PatSnap Eureka Desktop
NEWAnalytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisOpen Platform
NEWProfessional Services
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
Frontier
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report Mapping the 2026 continuous ketone monitor patent landscape: dual-analyte biosensors, breath acetone sensing, and wearable metabolic platforms reshaping diabetes care.
Article | Report Etavopivat (FT-4202) activates pyruvate kinase R to induce fetal hemoglobin without genome editing. Explore Phase 2/3 PEARL trial data and Novo Nordisk's IP strategy.
Article | Report Explore the 2026 landscape of CO₂ electroreduction catalyst materials: copper catalysts, SACs, MOFs, and key IP trends shaping carbon utilisation technology.
Article | Report No source data was provided for this topic. This page explains why the article cannot be produced and what steps are needed to generate a fully evidenced report.
Article | Report A 56-year patent and literature landscape of RLV heat shield technology: active cooling, deployable shields, ablative TPS, and emerging IP frontiers for 2026.
Article | Report Model predictive control vs reinforcement learning for industrial process optimization: key technical differences, trade-offs, and when to use each strategy.
Article | Report SGLT2 inhibitors empagliflozin and dapagliflozin are reshaping cardiorenal medicine. Explore the Phase III landscape, competitive IP signals, and what to do when data pipelines fail.
Article | Report Explore the 2026 landscape of lithium battery electrolyte additive materials: film-forming agents, SEI compounds, flame retardants, and overcharge protection.
Article | Report Near memory computing architecture in 2026: PIM, CIM, and LIM technology clusters, key innovators, application domains, and strategic IP implications.
Article | Report SUMMIT Phase III trial: tirzepatide's dual GLP-1/GIP agonism improved KCCQ-CSS, 6-minute walk distance, and reduced HF events in obesity-related HFpEF. Full analysis.
Article | Report Explore the key engineering challenges of scalable solid-state lighting systems for horticulture and vertical farming, from thermal management to spectral tuning.
Article | Report Explore the 2026 landscape of lithium battery separator coating materials — ceramic, polymer, and functional coatings — with patent intelligence from PatSnap Eureka.
Article | Report How semaglutide's ESSENCE Phase III trial targets MASH histology beyond obesity—dual endpoints, GLP-1 liver mechanisms, and the competitive pipeline explained.
Article | Report No patent or literature data was returned for this edge AI inference query. Learn why evidence-based publication requires verified sources and how to proceed.
Article | Report Explore the 2026 bioelectronic neural interface materials landscape: key research directions, patent search strategies, and how to navigate this evolving field.